Dot Decimal
Focus: Dot Decimal develops custom patient-specific cancer treatment devices, operating in the oncology space with a specialized focus on personalized medicine. The company is based in Sanford, FL and operates as a pre-revenue or early-stage biotechnology firm.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Dot Decimal?
AI assessmentDot Decimal presents a high-risk, early-stage opportunity suitable only for founders-minded professionals willing to tolerate uncertainty in exchange for potential equity upside and ground-floor impact in personalized oncology.
Why Work Here
- Pioneering role in personalized oncology devices with potential to shape future cancer treatment paradigms
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dot Decimal
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.